Schaefer-Graf U M, Buchanan T A, Xiang A, Songster G, Montoro M, Kjos S L
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles 90033, USA.
Am J Obstet Gynecol. 2000 Feb;182(2):313-20. doi: 10.1016/s0002-9378(00)70217-1.
We sought to determine the types of congenital anomalies affecting infants of women with gestational diabetes mellitus or type 2 diabetes and to examine the relationship between those malformation types and measures of initial glycemia of women at entry into prenatal care with type 2 diabetes or at time of diagnosis in women with gestational diabetes mellitus.
A total of 4,180 pregnancies complicated by gestational diabetes mellitus (n = 3764) or type 2 diabetes (n = 416) that were delivered after 20 weeks of gestation were reviewed for the presence of congenital malformations diagnosed before hospital discharge. Anomalies were categorized as being absent, minor, major, genetic syndromes, or aneuploidies. Major anomalies were further categorized by the number and type of affected organ systems. In addition to maternal clinical and historical parameters, the initial fasting serum glucose either from the diagnostic glucose tolerance test (gestational diabetes mellitus) or at entry to prenatal care (type 2 diabetes) and the initial glycosylated hemoglobin before insulin therapy were examined for a relationship to anomalies.
The initial fasting serum glucose and glycosylated hemoglobin levels were significantly higher in pregnancies with major (n = 143) and minor (n = 112) anomalies and genetic syndromes (n = 9) compared with pregnancies with no anomalies (n = 3895). Of those pregnancies with major anomalies, the most commonly affected organ systems were the cardiac (37.6%), musculoskeletal (14.7%), and central nervous systems (9.8%) and anomalies involving multiple organ systems (16%). There was no increased predominance of any specific organ system involvement seen with increasing fasting serum glucose levels in pregnancies with major congenital anomalies. Pregnancies with major anomalies affecting multiple organ systems had significantly higher initial fasting serum glucose levels (166 +/- 64 mg/dL) compared with pregnancies in which one organ system was affected (141 +/- 55 mg/dL, P <.04) or no organ systems were affected (115 +/- 38 mg/dL, P <.0001).
Congenital anomalies in offspring of women with gestational and type 2 diabetes affect the same organ systems that have been previously described in pregnancies complicated by type 1 diabetes. Increasing hyperglycemia at diagnosis or presentation for care was associated with an increasing risk of anomalies in general and with anomalies involving multiple organ systems without a preferential increase in involvement of specific organ system.
我们试图确定影响妊娠期糖尿病或2型糖尿病女性所生婴儿的先天性异常类型,并研究这些畸形类型与2型糖尿病女性进入产前护理时或妊娠期糖尿病女性诊断时的初始血糖测量值之间的关系。
对总共4180例妊娠进行了回顾,这些妊娠合并妊娠期糖尿病(n = 3764)或2型糖尿病(n = 416),妊娠20周后分娩,检查出院前诊断的先天性畸形情况。异常被分类为不存在、轻微、严重、遗传综合征或非整倍体。严重异常进一步按受影响的器官系统数量和类型分类。除了母亲的临床和病史参数外,还检查了诊断性葡萄糖耐量试验(妊娠期糖尿病)时的初始空腹血清葡萄糖或进入产前护理时(2型糖尿病)的初始空腹血清葡萄糖以及胰岛素治疗前的初始糖化血红蛋白与异常的关系。
与无异常的妊娠(n = 3895)相比,有严重(n = 143)、轻微(n = 112)异常和遗传综合征(n = 9)的妊娠中,初始空腹血清葡萄糖和糖化血红蛋白水平显著更高。在那些有严重异常的妊娠中,最常受影响的器官系统是心脏(37.6%)、肌肉骨骼(14.7%)和中枢神经系统(9.8%)以及涉及多个器官系统的异常(16%)。在有严重先天性异常的妊娠中,随着空腹血清葡萄糖水平升高,未见任何特定器官系统受累的优势增加。与一个器官系统受累的妊娠(141±55mg/dL,P<.04)或无器官系统受累的妊娠(115±38mg/dL,P<.0001)相比,有影响多个器官系统的严重异常的妊娠初始空腹血清葡萄糖水平显著更高(166±64mg/dL)。
妊娠期和2型糖尿病女性后代的先天性异常影响的器官系统与先前1型糖尿病合并妊娠中所描述的相同。诊断或就医时高血糖增加一般与异常风险增加相关,与涉及多个器官系统的异常相关,而特定器官系统受累无优先增加。